Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

130 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The NICE cost-effectiveness threshold: what it is and what that means.
McCabe C, Claxton K, Culyer AJ. McCabe C, et al. Among authors: claxton k. Pharmacoeconomics. 2008;26(9):733-44. doi: 10.2165/00019053-200826090-00004. Pharmacoeconomics. 2008. PMID: 18767894 Review.
An economic approach to clinical trial design and research priority-setting.
Claxton K, Posnett J. Claxton K, et al. Health Econ. 1996 Nov-Dec;5(6):513-24. doi: 10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO;2-9. Health Econ. 1996. PMID: 9003938
Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application.
Sculpher M, Fenwick E, Claxton K. Sculpher M, et al. Among authors: claxton k. Pharmacoeconomics. 2000 May;17(5):461-77. doi: 10.2165/00019053-200017050-00005. Pharmacoeconomics. 2000. PMID: 10977388 Review.
A dynamic programming approach to the efficient design of clinical trials.
Claxton K, Thompson KM. Claxton K, et al. J Health Econ. 2001 Sep;20(5):797-822. doi: 10.1016/s0167-6296(01)00093-5. J Health Econ. 2001. PMID: 11558649
Representing uncertainty: the role of cost-effectiveness acceptability curves.
Fenwick E, Claxton K, Sculpher M. Fenwick E, et al. Among authors: claxton k. Health Econ. 2001 Dec;10(8):779-87. doi: 10.1002/hec.635. Health Econ. 2001. PMID: 11747057
Pre-operative optimisation employing dopexamine or adrenaline for patients undergoing major elective surgery: a cost-effectiveness analysis.
Fenwick E, Wilson J, Sculpher M, Claxton K. Fenwick E, et al. Among authors: claxton k. Intensive Care Med. 2002 May;28(5):599-608. doi: 10.1007/s00134-002-1257-y. Epub 2002 Mar 26. Intensive Care Med. 2002. PMID: 12029409 Clinical Trial.
A rational framework for decision making by the National Institute For Clinical Excellence (NICE).
Claxton K, Sculpher M, Drummond M. Claxton K, et al. Lancet. 2002 Aug 31;360(9334):711-5. doi: 10.1016/S0140-6736(02)09832-X. Lancet. 2002. PMID: 12241891
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis.
Chilcott J, McCabe C, Tappenden P, O'Hagan A, Cooper NJ, Abrams K, Claxton K, Miller DH; Cost Effectiveness of Multiple Sclerosis Therapies Study Group. Chilcott J, et al. Among authors: claxton k. BMJ. 2003 Mar 8;326(7388):522; discussion 522. doi: 10.1136/bmj.326.7388.522. BMJ. 2003. PMID: 12623909 Free PMC article.
A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme.
Claxton K, Ginnelly L, Sculpher M, Philips Z, Palmer S. Claxton K, et al. Health Technol Assess. 2004 Jul;8(31):1-103, iii. doi: 10.3310/hta8310. Health Technol Assess. 2004. PMID: 15248937
Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J. Philips Z, et al. Among authors: claxton k. Health Technol Assess. 2004 Sep;8(36):iii-iv, ix-xi, 1-158. doi: 10.3310/hta8360. Health Technol Assess. 2004. PMID: 15361314 Review.
130 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback